
Researchers who study exceptional responders—patients who have dramatic and long-lasting responses to treatments for cancer that were not effective for most similar patients—met recently to exchange ideas and discuss the state of the science in this emerging field.
The NCI-sponsored meeting, held May 11 at NCI’s Shady Grove campus in Rockville, Maryland, featured updates on the Exceptional Responders Initiative, a pilot study that aims to gain insights into the biological mechanisms that give rise to these unusual responses to treatments.
By analyzing tumors from exceptional responders, the researchers hope to identify the genetic and molecular changes that underlie their responses to treatment. Such studies could also reveal biomarkers that could be used to predict responses to the same or similar treatments in other patients.
Source: NCI







